ATE399206T1 - Ribonukleoproteinkomplex aus paramyxovirus - Google Patents

Ribonukleoproteinkomplex aus paramyxovirus

Info

Publication number
ATE399206T1
ATE399206T1 AT00929790T AT00929790T ATE399206T1 AT E399206 T1 ATE399206 T1 AT E399206T1 AT 00929790 T AT00929790 T AT 00929790T AT 00929790 T AT00929790 T AT 00929790T AT E399206 T1 ATE399206 T1 AT E399206T1
Authority
AT
Austria
Prior art keywords
paramyxovirus
ribonucleoprotein complex
foreign gene
prepared
successfully
Prior art date
Application number
AT00929790T
Other languages
English (en)
Inventor
Kaio Kitazato
Tsugumine Shu
Hidekazu Kuma
Yasuji Ueda
Makoto Asakawa
Mamoru Hasegawa
Akihiro Iida
Takahiro Hirata
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of ATE399206T1 publication Critical patent/ATE399206T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00929790T 1999-05-18 2000-05-18 Ribonukleoproteinkomplex aus paramyxovirus ATE399206T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20074099 1999-05-18

Publications (1)

Publication Number Publication Date
ATE399206T1 true ATE399206T1 (de) 2008-07-15

Family

ID=16429391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00929790T ATE399206T1 (de) 1999-05-18 2000-05-18 Ribonukleoproteinkomplex aus paramyxovirus

Country Status (12)

Country Link
EP (1) EP1179594B1 (de)
JP (1) JP3766596B2 (de)
KR (1) KR100686514B1 (de)
CN (1) CN100352925C (de)
AT (1) ATE399206T1 (de)
AU (1) AU4777900A (de)
CA (1) CA2368944C (de)
DE (1) DE60039292D1 (de)
DK (1) DK1179594T3 (de)
ES (1) ES2307509T3 (de)
HK (1) HK1044175B (de)
WO (1) WO2000070055A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1186667T3 (da) * 1999-05-18 2007-10-22 Dnavec Research Inc Kappegendeficient virusvektor af Paramyxoviridae
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
KR100774796B1 (ko) * 2000-01-19 2007-11-07 가부시키가이샤 디나벡크 겐큐쇼 파라믹소바이러스 벡터의 혈관으로의 유전자 도입용도
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
DE60133767T2 (de) 2000-11-27 2009-06-25 Dnavec Research Inc., Tsukuba Für fibroblasten-wachstumsfaktor 2 (fgf2) kodierender paramyxovirus-vektor und dessen verwendung
AU2004286144A1 (en) 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
AU2005205441A1 (en) 2004-01-13 2005-07-28 Dnavec Research Inc. Gene therapy for tumor using minus-strand RNA virus vector encoding immunostimulating cytokine
CA2553976C (en) 2004-01-22 2013-09-24 Dnavec Research Inc. Method for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken .beta.-actin promoter
CN101006171A (zh) 2004-06-24 2007-07-25 株式会社载体研究所 含有单链负链rna病毒的抗癌剂
CA2612168A1 (en) 2005-06-14 2006-12-21 Dnavec Corporation Methods for producing antibodies
WO2006137517A1 (ja) * 2005-06-24 2006-12-28 Dnavec Corporation 幼少個体への遺伝子導入用ベクター
HUE028512T2 (en) 2005-10-28 2016-12-28 Id Pharma Co Ltd Gene transfer to airway epithelial stem cell using RNA virus spike protein pseudotyped lentiviral vector
KR20080094910A (ko) 2006-01-17 2008-10-27 디나벡크 가부시키가이샤 신규 단백질 발현계
KR20090027693A (ko) 2006-05-31 2009-03-17 디나벡크 가부시키가이샤 알츠하이머병 치료제
CN101646768A (zh) 2007-02-07 2010-02-10 生物载体株式会社 减毒负链rna病毒
EP2143794A1 (de) 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viraler vektor für gentherapie
EP2085479A1 (de) * 2008-01-31 2009-08-05 Institut Pasteur Reverse Genetik von Negativstrang-RNA-Viren in Hefe
DK2322611T3 (en) 2008-07-16 2016-09-05 Ip Pharma Co Ltd A process for producing reprogrammed cells using chromosomally non-integrated viral vector
CN102272302B (zh) 2008-10-31 2015-04-15 生物载体株式会社 增强重组蛋白表达的方法
JP5697044B2 (ja) 2010-01-08 2015-04-08 国立大学法人京都大学 タウオパチー治療用ワクチン
CN103097521A (zh) 2010-04-16 2013-05-08 学校法人庆应义塾 人工多能性干细胞的制造方法
JP5908838B2 (ja) 2010-08-30 2016-04-26 株式会社Ｉｄファーマ 多能性幹細胞を誘導するための組成物およびその使用
US20130302367A1 (en) 2010-10-22 2013-11-14 Hisatoshi Shida Virus vector for prime/boost vaccines, which comprises vaccinia virus vector and sendai virus vector
US10975358B2 (en) 2013-09-24 2021-04-13 Id Pharma Co., Ltd. Method for improving efficiency of inducing pluripotent stem cell
US11103574B2 (en) 2016-11-17 2021-08-31 Japan, as represented by the Director-General of National Institute of Infectious Disease Infectious disease vaccine using non-infectious paramyxovirus particle
EP3656858A4 (de) * 2017-07-21 2021-04-21 I'rom Group Co., Ltd. Polynukleotid zur modifizierung von zielsequenzen und dessen verwendung
WO2019142933A1 (ja) 2018-01-22 2019-07-25 国立感染症研究所長が代表する日本国 選択的ｃｄ８陽性ｔ細胞誘導ワクチン抗原
JP7808298B2 (ja) 2020-09-04 2026-01-29 Ｈｅａｒｔｓｅｅｄ株式会社 ｉＰＳ細胞の品質改善剤、ｉＰＳ細胞の製造方法、ｉＰＳ細胞、及びｉＰＳ細胞製造用組成物
WO2022138964A1 (ja) 2020-12-25 2022-06-30 国立大学法人京都大学 体細胞からのナイーブ型ヒトｉＰＳ細胞製造方法
WO2023053220A1 (ja) 2021-09-28 2023-04-06 公益財団法人京都大学ｉＰＳ細胞研究財団 多能性幹細胞の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016171A1 (fr) * 1995-11-01 1997-05-09 Dnavec Research Inc. Liposome a membrane fusible faisant appel a un virus sendai recombinant

Also Published As

Publication number Publication date
JP3766596B2 (ja) 2006-04-12
DE60039292D1 (de) 2008-08-07
CN1357044A (zh) 2002-07-03
HK1044175B (en) 2008-11-14
AU4777900A (en) 2000-12-05
CA2368944A1 (en) 2000-11-23
KR100686514B1 (ko) 2007-02-23
EP1179594B1 (de) 2008-06-25
CA2368944C (en) 2010-07-27
EP1179594A1 (de) 2002-02-13
CN100352925C (zh) 2007-12-05
KR20010113875A (ko) 2001-12-28
HK1044175A1 (en) 2002-10-11
ES2307509T3 (es) 2008-12-01
WO2000070055A1 (en) 2000-11-23
EP1179594A4 (de) 2003-04-02
DK1179594T3 (da) 2008-09-01

Similar Documents

Publication Publication Date Title
DE60039292D1 (de) Ribonukleoproteinkomplex aus paramyxovirus
DE69833649D1 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
DE60038011D1 (de) Verbesserung der immunantwort als anwendung in impfstoff und gentherapie
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
ATE236261T1 (de) Dna-expressionssysteme basierend auf alphaviren
WO1999020766A3 (en) NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
WO2001029222A3 (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
EP1368467A4 (de) Putrescin-n-methyltransferasepromotor
WO2002044390A3 (en) Floral development genes
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
DE502006006865D1 (de) Neue dehydrogenasen, deren derivate und ein verfahren zur herstellung von optisch aktiven alkanolen
DE502004006579D1 (de) L-carnitin dehydrogenasen, deren derivate und ein verfahren zur herstellung von substituierten (s)-alkanolen
DE69734828D1 (de) 5-aminolevulinsaure synthase aus aspergillus oryzae und dafuer kodierende nukleinsaeure
WO1999053069A3 (en) Cell cycle regulatory proteins cdc2 and pitslre from plants
WO2000068389A3 (en) Auxin transport proteins
WO2000066743A3 (en) Viral expression vectors
DE60040077D1 (de) Vermehrungsproteine von pflanzen
ATE288491T1 (de) Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren
WO1999048486A3 (en) Plant cell cyclin genes
DE602004010788D1 (de) Hühner-rna-polymerase-i-promotor und deren verwendung
WO2003057824A3 (en) Compositions and methods for the inhibition of membrane fusion by paramyxoviruses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1179594

Country of ref document: EP

REN Ceased due to non-payment of the annual fee